APP and Alzheimer disease: In the transgenic model of AD with increasing amyloid beta burden, the expression of NgR1 on reactive microglia in APP/PS1 transgenic mice was identified, which was correlated to NF-κB/STAT3 activation in these reactive cells during inflammatory progression [155].